Patient and Clinical Characteristics
Number (%) of Patients (n = 635)* | |
---|---|
Age, y | |
Mean (SD) | 60.9 (15.6) |
Range | 18.0 to 95.0 |
Gender | |
Men | 182 (28.7) |
Women | 453 (71.3) |
BMI† | |
Mean (SD) | 27.8 (6.0) |
Range | 14.9 to 49.0 |
Chronic health conditions‡ | |
CAD | 56 (8.8) |
Cancer | 35 (5.5) |
CHF | 35 (5.5) |
GAD | 153 (24.1) |
Hyperlipidemia | 318 (50.1) |
Hypertension | 312 (49.1) |
MDD | 137 (21.6) |
OSA | 103 (16.2) |
Prediabetes | 66 (10.4) |
Type 2 diabetes | 68 (10.7) |
OTC medications, number | |
Mean (SD) | 3.2 (2.5) |
Range | 0.0 to 15.0 |
Rx medications, number | |
Mean (SD) | 4.5 (3.5) |
Range | 0.0 to 19.0 |
Medications, type | |
Anticoagulant | 50 (7.9) |
Antidepressant | 118 (18.6) |
Antihypertensive | 280 (44.1) |
Anxiolytic | 80 (12.6) |
BPH medicine | 19 (3.0) |
GERD medicine | 149 (23.5) |
Insulin | 25 (3.9) |
Opioid | 51 (8.0) |
Oral hypoglycemic | 59 (9.3) |
Sleep aid | 76 (12.0) |
Statin | 211 (33.2) |
↵* Unless indicated otherwise.
↵†Calculated as weight in kilograms divided by height in meters squared.
↵‡Some patients had more than 1 chronic condition.
Abbreviations: BMI, body mass index; BPH, benign prostatic hyperplasia; CAD, coronary artery disease; CHF, congestive heart failure; GAD, generalized anxiety disorder; GERD, gastroesophageal reflux disease; MDD, major depressive disorder; OSA, obstructive sleep apnea; OTC, over-the-counter; Rx, prescription; SD, standard deviation.